SEC Form 4 · accession 0001209191-16-088951
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel S Marcus
Director
Period of report
Dec 31, 2015
Accepted (ET)
Jan 5, 2016 · 5:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 31, 2015 | A | 199 | $53.79 | A | 18,921 | D | |
| Common StockF1 | holding | — | — | — | 1,191,156 | I | See Footnote | |
| Common Stock | holding | — | — | — | 15,742 | I | Held by the Joel S. Marcus and Barbara A. Marcus Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of shares of common stock held by Alexandria Equities, LLC. Mr. Marcus is the Chairman, CEO and Founder of Alexandria Real Estate Equities, Inc., which is the managing member of Alexandria Equities, LLC, which has full voting and investment power with respect to the shares owned by Alexandria Equities, LLC. As an officer of Alexandria Real Estate Equities, Inc., Mr. Marcus may be deemed to have voting and investment power with respect to the shares owned by Alexandria Equities, LLC. Mr. Marcus disclaims beneficial ownership of the shares held by Alexandria Equities, LLC, except to the extent of his underlying pecuniary interest therein.